삼성물산 028260
Intraday as of Oct 14
₩300,000 0.00%
Low ₩193,300 52-week range High ₩565,000
Apr 1 ~ Oct 14
₩300,000 +9.89%
1M 3M 6M
Low ₩263,000 High ₩535,000
Net flow, Neutral
Multi-day trend, Mixed
Cumulative flow -₩12B Estimated from public price, change and volume. Not actual investor net buying.
Lending balance Building 1D +1.03% 5D +2.56%
New 107,971 sh, Returned 84,703 sh
Shares borrowed through securities lending that have not yet been returned. Borrowed shares are often sold afterwards, so the balance is used as a reference for pending sell pressure.
As of 2026-10-12, FSC stock lending data
0 to check first, 6 improvements checked through Oct 14
This only counts facts confirmed in filings. It does not look at whether the price is cheap or expensive, and it is not a reason to buy or sell on its own.
Company research researched Sep 22 The 73.96 trillion won valuation gain on Samsung Electronics and other shareholdings over six months appears nowhere in half-year net profit of 2,001.4 billion won.
Samsung C&T reports revenue in six segments: construction, trading, fashion, resort, food services, and biologics, the last made up of Samsung Biologics and Samsung Epis Holdings, in each of which it holds 43.06%. Consolidated revenue for the second quarter of 2026 was 11,995.1 billion won and operating profit 1,031.7 billion won, and the biologics segment accounted for 61.0% of first-half operating profit of 1,752.1 billion won. Of total assets of 163.77 trillion won at the end of June, 118.87 trillion won sat in financial assets measured at fair value through other comprehensive income, including a 4.49% stake in Samsung Electronics. The 73.96 trillion won valuation gain on those shares in the first half went to other comprehensive income, leaving half-year net profit of 2,001.4 billion won and earnings per share of 8,798 won untouched.
Q2 revenue 11,995.1 billion won
Q2 operating profit 1,031.7 billion won
Total assets, end of June 163.77 trillion won
Samsung Electronics stake, carrying amount 99.81 trillion won
Biologics share of H1 operating profit 61.0%
Construction order backlog 34.24 trillion won Read the full research
Company profile Unqualified opinion 삼성물산(주)
CEO 오세철, 이재언, 송규종
Employees 9,261
Average tenure 15 years
Average pay per employee ₩123M
Listed 2014-12-18
Founded 1963-12-23
Auditor 삼일회계법인 Samsung C&T changed 0.00%. The 5 covered Industrials stocks in Korean averaged +1.29%, with estimated sector flow of inflow.
Variables to watch Order backlog, Oil prices, China demand, USD/KRW
Risks to check -47% below the high, the downtrend may continue, Order delays, Rising input costs
Same-sector channels
Posts are members' opinions. Investment decisions and their consequences are your own.
Data: KRX daily bars, InverseOne quote snapshots, public news feeds, DART filings, InverseOne company research. Not a call to buy or sell.
